comparemela.com
Home
Live Updates
Presents Landmark Trial - Breaking News
Pages:
Presents Landmark Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana
NRX-101: First Antidepressant to Lower Suicidality in Bipolar Depression
Unlike approved antidepressant drugs which have warnings on their labels stating they may increase the suicide risk, NRX-101 demonstrates meaningful reductions in suicidality.
United states
Miami beach
New york
Andrew nierenberg
Jonathan javitt
Drug administration
American psychiatric association
Dauten family center
Nrx pharmaceuticals nasdaq
Psychiatry at harvard medical school
American society of clinical psychopharmacology
Nrx pharmaceuticals
Massachusetts general hospital
American society
Clinical psychopharmacology
Chief scientist
vimarsana © 2020. All Rights Reserved.